Giuseppe Bruno

Pubblicazioni

Titolo Pubblicato in Anno
Neuroanatomical and clinical correlates of prodromal dementia with Lewy bodies: a systematic literature review of neuroimaging findings JOURNAL OF NEUROLOGY 2025
Abnormal electroencephalographic rhythms from quiet wakefulness to light sleep in Alzheimer's disease patients with mild cognitive impairment CLINICAL NEUROPHYSIOLOGY 2025
Alpha rhythm and Alzheimer's disease: Has Hans Berger's dream come true? CLINICAL NEUROPHYSIOLOGY 2025
Salivary biomarkers for the molecular diagnosis of dementia with Lewy bodies JOURNAL OF ALZHEIMER'S DISEASE 2025
Association of Early fMRI Connectivity Alterations With Different Cognitive Phenotypes in Patients With Newly Diagnosed Parkinson Disease NEUROLOGY 2025
Frailty and urinary symptoms share pathophysiological mechanisms involved in disease progression in people with multiple sclerosis NEUROLOGICAL SCIENCES 2025
Blood count and renal functionality assessments in the emergency section disclose morbidity and ortality in omicron COVID-19 patients: a retrospective study CLINICS AND PRACTICE 2024
Distinct grey and white matter changes are associated with the phenomenology of visual hallucinations in Lewy Body Disease SCIENTIFIC REPORTS 2024
Neuroretinal and microvascular retinal features in dementia with Lewy body assessed by optical coherence tomography angiography NEUROLOGICAL SCIENCES 2024
BPSDiary study protocol: a multi-center randomized controlled trial to compare the efficacy of a BPSD diary vs. standard care in reducing caregiver's burden. FRONTIERS IN DEMENTIA 2024
miR-92a-3p and miR-320a are Upregulated in Plasma Neuron-Derived Extracellular Vesicles of Patients with Frontotemporal Dementia MOLECULAR NEUROBIOLOGY 2024
Sex-specific clinical and neurobiological correlates of fatigue in older adults GEROSCIENCE 2024
Smelling TNT: trends of the terminal nerve INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2024
Proteoform analysis of the human olfactory system: a window into neurodegenerative diseases PROTEOMES 2024
Neuropsychological Effects of the Lockdown Due to the COVID-19 Pandemic on Patients with Alzheimer’s Disease and Their Caregivers: The “ACQUA” (Alzheimer–COVID QUArantine Questionnaire) Study INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2024
Blood Biomarkers from the Emergency Department Disclose Severe Omicron COVID-19-Associated Outcomes MICROORGANISMS 2023
Identification of miRNAs regulating MAPT expression and their analysis in plasma of patients with dementia FRONTIERS IN MOLECULAR NEUROSCIENCE 2023
Frailty and relapse activity in multiple sclerosis: A longitudinal observation MULTIPLE SCLEROSIS AND RELATED DISORDERS 2023
Biomarkers of neurological damag. From acute stage to post-acute sequelae of covid-19 CELLS 2023
Facial emotion expressivity in patients with Parkinson's and Alzheimer's disease JOURNAL OF NEURAL TRANSMISSION 2023

ERC

  • LS5_11

Interessi di ricerca

Neurologia cognitiva; epidemiologia, genetica, clinica e neurofarmacologia della malattia di Alzheimer e altre demenze e delle malattie extrapiramidali con particolare riferimento alla sperimentazione di nuove procedure diagnostiche e terapeutiche (studi di neurofarmacologia clinica di fase 2-3-4) disturbi neuropsichiatrici; prevenzione dei disturbi cognitivi; nuove metodiche di somministrazione farmacologica e relative strategie terapeutiche in accordo con GCP.

Laboratori di ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma